Madeleine Richer
Madeleine Richer has a total of 24 co-authors. Here are the top co-authors by number of shared publications:
- Alejandro Martinez-Carrasco
Department of Clinical and Movement Neurosciences, Queen Square Institute of Neurology, University College London, London, UK
1 shared publication - Andrew B. Singleton
Center for Alzheimer’s and Related Dementias, National Institutes of Health, Bethesda, MD 20892, USA
1 shared publication - Bradford Casey
The Michael J. Fox Foundation for Parkinson’s Research, New York, USA
1 shared publication - Caroline B. Pantazis
Center for Alzheimer’s and Related Dementias (CARD), National Institute on Aging and National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD 20814, USA
1 shared publication Claire E. Wegel
Department of Medical and Molecular Genetics, Indiana University School of Medicine, Indianapolis, USA
1 shared publicationClodagh Towns
Department of Clinical and Movement Neurosciences, Queen Square Institute of Neurology, University College London, London, UK
1 shared publication
Latest Publications
- 15 February 2025
- Published by Elsevier in DNA Repair
- Vol. 147, 103817
Therapeutic targeting of mismatch repair proteins in triplet repeat expansion diseases
- 15 February 2025
- Published by Elsevier in DNA Repair
- Vol. 147, 103817
Therapeutic targeting of mismatch repair proteins in triplet repeat expansion diseases
- Open Access
- 12 September 2023
- Published by Springer Nature in npj Parkinson's Disease
- Vol. 9 (1) , 1-6
Defining the causes of sporadic Parkinson’s disease in the global Parkinson’s genetics program (GP2)
The Global Parkinson’s Genetics Program (GP2) will genotype over 150,000 participants from around the world, and integrate genetic and clinical data for use in large-scale analyses to dramatically expand our understanding of the genetic architecture of PD. This report details the workflow for cohort integration into the complex arm of GP2, and together with our outline of the monogenic hub in a companion paper, provides a generalizable blueprint for establishing large scale collaborative research consortia.
- 12 September 2023
- Published by Springer Nature in npj Parkinson's Disease
- Vol. 9 (1) , 1-6
Open AccessDefining the causes of sporadic Parkinson’s disease in the global Parkinson’s genetics program (GP2)
The Global Parkinson’s Genetics Program (GP2) will genotype over 150,000 participants from around the world, and integrate genetic and clinical data for use in large-scale analyses to dramatically expand our understanding of the genetic architecture of PD. This report details the workflow for cohort integration into the complex arm of GP2, and together with our outline of the monogenic hub in a companion paper, provides a generalizable blueprint for establishing large scale collaborative research consortia.